Creative Medical Technology Holdings Develops AlloStem™ Clinical Cell Line

Creative Medical Technology Holdings

PHOENIX, Oct. 20, 2022 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, neurology, and orthopedics, announced today that through predominantly internal and collaborative development, it has produced an allogenic Cell Line called AlloStem™, which includes a Master Cell Bank and a Drug Master File which shall […]

Global Mesenchymal Stem Cells (MSC) Market to Reach $6.5 Billion by 2027

Report Linker logo

New York, Oct. 19, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Mesenchymal Stem Cells (MSC) Industry” – https://www.reportlinker.com/p05961465/?utm_source=GNWOnline interactive peer-to-peer collaborative bespoke updatesAccess to our digital archives and MarketGlass Research PlatformComplimentary updates for one year Global Mesenchymal Stem Cells (MSC) Market to Reach $6.5 Billion by 2027 Amid the COVID-19 crisis, […]

Discover Medical Advances in Cellular Therapy Research Using Cord Blood for Cancer, HIV, Cerebral Palsy and Autism During World Cord Blood Day 2022

Save the Cord Foundation - Announcing speakers for free virtual conference

Free virtual conference for World Cord Blood Day 2022 (November 15th) to feature renowned transplant doctors and researchers presenting ground-breaking work in cellular therapy using cord blood to treat cancer, HIV, cerebral palsy and autism. In addition, bestselling author, Delia Ephron, to present her memoir about fighting leukemia, “Left on 10th: A Second Chance at Life.” […]

BREAKTHROUGH TECHNOLOGY FOR IPS-DERIVED CELL THERAPIES TURNED INTO GMP PLATFORM BY TREEFROG THERAPEUTICS & INVETECH

TreeFrog's C-Stem technology

BORDEAUX, France, Oct. 11, 2022 /PRNewswire/ — TreeFrog Therapeutics, a biotechnology company developing stem cell-derived therapies in regenerative medicine and immuno-oncology based on the biomimetic C-Stem™ technology platform, and Invetech, a global leader in the development and production of automated manufacturing solutions for cell and advanced therapies, today announced the delivery of a GMP-grade cell encapsulation device using the C-Stem™ technology. […]

Orchard Announces Multiple Presentations at 2022 ESGCT Annual Congress Showing the Potential of HSC Gene Therapy in Several Therapeutic Areas

Orchard Therapeutics

BOSTON and LONDON, Oct. 10, 2022 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced multiple presentations at the 29th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT), taking place October 11-14, 2022, in Edinburgh. Clinical and pre-clinical data from across the company’s hematopoietic stem cell […]

Searching for a Spina Bifida Cure Part 1 – The Promise of Stem Cells

Searching for a Spina Bifida Cure Part 1 - The Promise of Stem Cells

The first ever in utero stem cell treatment for spina bifida is the culmination of decades of work from UC Davis surgeon-scientist Diana Farmer. This novel fetal surgery at UC Davis Children’s Hospital could change the life of a developing baby with spina bifida, who otherwise could be born paralyzed from the waist down. In […]

Bone Marrow Transplant and Cell Therapies Unit at Tampa General Hospital Brings More Treatment Options to Cancer Patients

Tampa General Hospital

TAMPA, Fla., Oct. 3, 2022 /PRNewswire/ — As part of its commitment to world-class, innovative cancer care for the Tampa Bay region and beyond, Tampa General Hospital (TGH) Cancer Institute has established an adult Bone Marrow Transplant (BMT) and Cell Therapies unit that focuses on treating patients with aggressive blood cancers such as leukemias, lymphomas, multiple […]